JPMorgan Chase & Co. 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-06 10:35 am Sale |
2022-11-30 | 13G | G1 Therapeutics, Inc. GTHX |
JPMORGAN CHASE & CO JPM |
2,045,814 4.000% |
-94,034 (-4.39%) |
Filing |
| 2022-01-21 11:43 am Purchase |
2021-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
JPMORGAN CHASE & CO JPM |
2,139,848 5.000% |
2,139,848 (New Position) |
Filing |